← Back to Search

MRI for Magnetic Resonance Imaging (MRI)

Phase < 1
Waitlist Available
Led By Edward DiBella, Ph.D.
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time in the scanner to be 60-90 minutes.
Awards & highlights

Study Summary

This trial is looking to develop new methods to identify heart failure with preserved ejection fraction (HFpEF). These new methods will include robust methods for MRI, quantitative perfusion methods, and fibrosis quantification.

Eligible Conditions
  • Magnetic Resonance Imaging (MRI)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time in the scanner to be 60-90 minutes.
This trial's timeline: 3 weeks for screening, Varies for treatment, and time in the scanner to be 60-90 minutes. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Image quality improvement

Trial Design

1Treatment groups
Experimental Treatment
Group I: MRI vs.PET with/without Cardiac diseaseExperimental Treatment5 Interventions
Adenosine Regadenoson O-15 Labeled radioactive water MRI PET Imaging
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Adenosine
FDA approved
Regadenoson
FDA approved
PET Imaging
2008
Completed Phase 3
~380
MRI
2009
Completed Phase 2
~1370

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,589 Total Patients Enrolled
2 Trials studying Magnetic Resonance Imaging (MRI)
20 Patients Enrolled for Magnetic Resonance Imaging (MRI)
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,494 Total Patients Enrolled
Edward DiBella, Ph.D.Principal Investigator - Faculty
University of Utah
1 Previous Clinical Trials
1 Trials studying Magnetic Resonance Imaging (MRI)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have enrolled in this trial thus far?

"Affirmative. According to the information listed on clinicaltrials.gov, this research is presently recruiting subjects. It was initially posted on March 3rd 2017 and most recently updated October 21st 2020; 100 patients are required from 1 medical site."

Answered by AI

Are there any openings to participate in this research experiment?

"Correct. Information hosted on clinicaltrials.gov confirms that this research endeavour, which was first announced on March 3rd 2017, is actively recruiting. Approximately 100 participants must be found at a single medical facility."

Answered by AI

In what medical scenarios is MRI regularly recommended?

"Magnetic Resonance Imaging (MRI) is a viable option for treating myocardial scintigraphy, perfusion imaging of the heart muscle, and anomalous atrioventricular excitation."

Answered by AI
~12 spots leftby Apr 2025